A 68‑year‑old man with nonvariceal UGIB underwent successful endoscopic therapy. Which discharge PPI plan aligns with guideline after the 3‑day high‑d...

Question

A 68‑year‑old man with nonvariceal UGIB underwent successful endoscopic therapy. Which discharge PPI plan aligns with guideline after the 3‑day high‑dose phase?

Accepted Answer

Standard‑dose oral PPI twice daily for 2 weeks

Answer

No PPI thereafter

Answer

Continue high‑dose IV PPI indefinitely

Answer

H₂‑blocker only

Answer

Sucralfate only

us-abim MCQ (SBA): UGIB (Post‑Discharge PPI)

A 68‑year‑old man with nonvariceal UGIB underwent successful endoscopic therapy. Which discharge PPI plan aligns with guideline after the 3‑day high‑dose phase?